Flatiron Health Inc, founded in New York, focuses on transforming cancer care through advanced healthcare technology. The company's core mission is to provide oncologists and hospitals with comprehensive patient data to enhance treatment outcomes. Their services include designing and operating clinical trials, accelerating drug development, and improving patient care through real-world evidence (RWE) solutions. Flatiron Health serves a global market, aiming to improve every person’s experience with cancer.
Notable affiliated individuals include co-founders Nat Turner and Zach Weinberg. The company has attracted significant investment from entities like Roche, which acquired a majority stake in 2018. Key achievements include pioneering the use of RWE in oncology and forming partnerships with leading cancer centers and pharmaceutical companies. Flatiron Health's impact is evident in its contribution to more efficient clinical trials and improved cancer treatment protocols worldwide.
